Bioplax Limited is an investing company in the medical field, with oral products related. The companys strong points are its international patents, health registrations in various countries, and clinical and scientific evidences (ie. the quality, safety and efficacy of its products). Bioplax Limited engineered and developed a line of Medical Devices exclusively devoted to answer to the pathology of R.O.A.U. (Recurrent Oral Aphtous Ulceration) branded Aftamed® already distributed with success in the most important EU countries. The company is looking for qualified distributors to open new territories worldwide; please consult the distributors section.
| Website | http://www.bioplaxpharma.com |
| Revenue | $8 million |
| Employees | View employees |
| Address | 78 Stafford Rd, London, Essex SM6 9AY, GB |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Vital Bio, Pure Bioscience, Synergy Pharmaceuticals Inc., PharmaGreen Pharmaceuticals LTD., Ecopharma, BioGreen Solutions Canada Inc., BioVantage, BioSynergy Health Alternatives, Pharm-Eco Laboratories , Inc., BioHarvest Sciences +4 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Bioplax employee's phone or email?
Bioplax Questions
The Bioplax annual revenue was $8 million in 2026.
Bioplax is based in London, Essex.
The NAICS codes for Bioplax are [32541, 325, 32, 3254].
The SIC codes for Bioplax are [283, 28].
